Skip to Menu Skip to Search Contact Us Skip to Content
US Flag

You are accessing SGS’s website from the USA.

Visit the US website instead

Stay on the global website and remember my choice


SGS will be an exhibitor at the 2nd Annual Biosimilars and Biobetters Congress in the UK, which will be attended by more than 400 delegates representing leading biotech companies, global pharma organizations and internationally renowned academic institutions.


April 3, 2014


April 4, 2014


United Kingdom

Over 400 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.

25 presentations, case studies and panel discussions focused on the key issues in follow-on biologics development and commercialisation.

2 interactive streams:

  • Market Opportunities and Commercial Challenges
  • Developing Biosimilars and Biobetters

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.

Co-located with the 7th Annual Proteins & Antibodies Congress & the Peptides Congress Oxford Global are proud to present the Biosimilars & Biobetters Congress, taking place on 3-4 April 2014 at Novotel London West, UK.

The follow on biologics industry is forecast to reach $8.8 billion by 2017. Our conference programme focuses on the challenges, innovations and technologies that promise to put this sector at the forefront of the pharmaceutical industry.

The 2nd Annual Biosimilars and Biobetters Congress features two streams:

Market Opportunities & Commercial Challenges: In Stream 1, the meeting will discuss key strategies for overcoming regulatory challenges, gaining access to emerging markets and commercialising biosimilars. The programme also covers the leading advancements in substitution and interchangeability of biosimilars.

Developing Biosimilars & Biobetters: Learn more about current developments in clinical trials, including pharmacovigilance and patient safety. Our internationally renowned speakers will also explore the critical issues in developing biosimilars, including achieving quality by design and demonstrating biosimilarity. Do not miss out on hearing the latest insights into regulatory requirements and trial design.

Come and meet SGS experts at booth #12 to discuss your future projects and activities.
Dr Fiona Greer will be the chairman of Day 2 stream on Developing Biosimilars and Biobetters.

For more information on this event and to register your place, please visit the 2nd Annual Biosimilars & Biobetters Congress 2014 website.